Weizmann Institute
עברית

Weizmann Wonder Wander

You are here

Home > Topics > Technology > Biotechnology

Biotechnology

Technology

Yeda Technology Transfer
Benefiting Humanity
Biotechnology
Diagnostic Techniques and Drugs
Amir Naiberg, Prof. Mudi Sheves, Stefan Oschmann and Belén Garijo

Merck and Weizmann Institute Sign New Framework Agreement on Research Collaboration

16.02.2016
Yeda Technology Transfer, Biotechnology, Diagnostic Techniques and Drugs
Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, by signing a new...
cancer-free prostate

Weizmann Institute Drug, TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico

04.01.2016
Life Sciences, Biochemistry, Cancer, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Biotechnology, Diagnostic Techniques and Drugs
(l-r) Eyal Karzbrun, Alexandra Tayar and Prof. Roy Bar-Ziv

Artificial Cells Produce Real Proteins

27.10.2014
Molecular and Cell Biology, Genetics, Materials Science, Biotechnology
"Cells on a chip" are beginning to recreate biological processes
(l-r) Eyal Karzbrun, Alexandra Tayar and Prof. Roy Bar-Ziv

Artificial Cells Act Like the Real Thing

18.08.2014
Molecular and Cell Biology, Genetics, Materials Science, Biotechnology
Cell-like compartments produce proteins and communicate with one another, similar to natural biological systems  
rewriting DNA illustration

Rewriting DNA to Understand What it Says

31.05.2012
Molecular and Cell Biology, Genetics, Math & Computer Science, Biotechnology
New Weizmann Institute technology speeds up DNA “rewriting” and measures the effects of the changes in living cells  
Prof. Irun Cohen, DiaPep 227 developer

Phase III Clinical Trials of Diabetes Treatment

30.01.2012
Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Biotechnology
Initial results show higher pancreas function after two years of treatment
Andromeda Biotech: A Drug for Type 1 Diabetes Developed by Prof. Irun Cohen of the Weizmann Institute Meets Primary and Secondary Goals of Phase III Clinical Trials

Andromeda Biotech: A Drug for Type 1 Diabetes Developed by Prof. Irun Cohen of the Weizmann Institute Meets Primary and Secondary Goals of Phase III Clinical Trials

22.11.2011
Disease, Drugs & Diagnostics, Biotechnology
Pateints receiving the drug had significantly higher pancreas function than those in the control group.
(l-r) Drs. Eyal Rotenberg and David Asaf, Prof. Dan Yakir and Yakir Preisler. Lab on wheels

Environmental Research Goes on the Road

04.11.2011
Environment, Energy, Biotechnology
With the new Biosphere-Atmosphere Research Mobile Lab, researchers now can bring the lab to the forest. 
The Inside View

The Inside View

01.05.2007
Math & Computer Science, Computer Vision, Biotechnology
"Seeing" computers might, in the future, help diagnose disease
An electric current can flow forever in superconductors because nothing in them wears it down

Electricity's Free Ride

01.11.2003
Materials Science, Biotechnology
An electric current can flow forever in superconductors because nothing in them wears it down    

Pages

Top Stories

See All >
self-driving dashboard

The Human Test for Computer-Written Code

infrared silkworm

Microscopic Silk Cocoons May Facilitate Drug Design

Mars impact

Minerals in a Family of Asteroids Reveal Martian Roots

Prof. Itamar Procaccia

Prof. Itamar Procaccia

Press Releases

See All >
infrared silkworm
20.07.2017
Microscopic Silk Cocoons May Facilitate Drug Design
Weizmann House
03.07.2017
Weizmann House Reopens to the Public
dust storm
27.06.2017
The Dust Storm Microbiome

.